Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Apply
SX-682 & Enzalutamide
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step